UL Solutions director granted stock unit awards
SUSMAN SALLY reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SUSMAN SALLY reported acquisition or exercise transactions in this Form 4 filing.
UL Solutions Inc. director Sally Susman reported routine equity compensation in the form of stock units. On June 8, 2026, she received awards of 3 Restricted Stock Units (RSUs), 4 Deferred Restricted Stock Units (DRSUs), and an additional 7 DRSUs, each at a price of $0.00 per unit.
Each RSU or DRSU represents a contingent right to receive one share of Class A common stock. The filing notes that these awards largely reflect accrued dividend equivalent rights on previously granted units, which vest proportionately with the underlying RSUs or DRSUs under the company’s non-employee director deferred compensation plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Restricted Stock Units | 7 | $0.00 | $0.00 |
| Grant/Award | Deferred Restricted Stock Units | 4 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 3 | $0.00 | $0.00 |
Footnotes (8)
- F1. Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.
- F3. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
- F4. Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.
- F5. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
- F6. Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person.
- F7. The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date.
- F8. Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date.
Key Figures
Key Terms
Restricted Stock Units financial
Deferred Restricted Stock Units financial
dividend equivalent rights financial
Non-Employee Director Deferred Compensation Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did UL Solutions (ULS) director Sally Susman report in this Form 4?
How many UL Solutions (ULS) restricted stock units did the director receive?
Are these UL Solutions (ULS) Form 4 transactions open-market buys or sells?
What do UL Solutions (ULS) dividend equivalent rights mean in this filing?
When will the reported UL Solutions (ULS) stock units vest and settle?
AI-generated analysis. How Rhea-AI works. Not financial advice.